跳至主要内容
临床试验/NL-OMON48390
NL-OMON48390已完成不适用

Molecular phenotyping of Mast Cells in Indolent Systemic Mastocytosis using Single Cell RNA-sequencing - MC-ISM

niversitair Medisch Centrum Groningen0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - A clinical suspicion of ISM, based on a constellation of clinical complaints,
  • including drowsiness, gastro-intestinal complaints, myalgia and fatigue, or
  • manifestations such as urticaria pigmentosa, osteoporosis or anaphylaxis.
  • - Eligible for a bone marrow biopsy
  • - Legally capacitated adults
  • -The second eligible patient group concerns patient enrolled in the
  • avapritinib study (research register number 201800849, METc 2018.635). These
  • patients with a confirmed diagnosis of ISM willl undergo a bone marrow biopsy
  • as part of the study protocol of the avapritinib study. Therefore, also in this
  • patient population no additional invasive procedures are required, hence the
  • additional burden of the current study remains restricted to the withdrawal of
  • the additional sample.

排除标准

  • Lidocaine hypersensitivity.

研究者

相似试验